{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:21:43Z","timestamp":1786980103924,"version":"build-2736575974"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T00:00:00Z","timestamp":1718409600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"DOI":"10.1007\/s00403-024-03117-7","type":"journal-article","created":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T08:01:52Z","timestamp":1718438512000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Vitiligo and the metabolic syndrome: clarifying the inconsistent relationship by a large-scale population-based study"],"prefix":"10.1007","volume":"316","author":[{"given":"Khalaf","family":"Kridin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keren","family":"Lyakhovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masad","family":"Barhoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lyakhovitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,15]]},"reference":[{"key":"3117_CR1","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/S40257-017-0298-5","volume":"18","author":"R Speeckaert","year":"2017","unstructured":"Speeckaert R, van Geel N, Vitiligo (2017) An update on pathophysiology and treatment options. Am J Clin Dermatol 18:733\u2013744. https:\/\/doi.org\/10.1007\/S40257-017-0298-5","journal-title":"Am J Clin Dermatol"},{"key":"3117_CR2","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/S0140-6736(14)60763-7","volume":"386","author":"K Ezzedine","year":"2015","unstructured":"Ezzedine K, Eleftheriadou V, Whitton M, van Geel N, Vitiligo (2015) Lancet 386:74\u201384. https:\/\/doi.org\/10.1016\/S0140-6736(14)60763-7","journal-title":"Lancet"},{"key":"3117_CR3","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1016\/S0140-6736(05)66378-7","volume":"365","author":"RH Eckel","year":"2005","unstructured":"Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1415\u20131428. https:\/\/doi.org\/10.1016\/S0140-6736(05)66378-7","journal-title":"Lancet"},{"key":"3117_CR4","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1111\/PCMR.12941","volume":"34","author":"Y Azzazi","year":"2021","unstructured":"Azzazi Y, Mostafa WZ, Sayed KS et al (2021) Support for increased cardiovascular risk in non-segmental vitiligo among egyptians: a hospital-based, case\u2013control study. Pigment Cell Melanoma Res 34:598\u2013604. https:\/\/doi.org\/10.1111\/PCMR.12941","journal-title":"Pigment Cell Melanoma Res"},{"key":"3117_CR5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.4103\/IJD.IJD_360_16","volume":"62","author":"L Raveendra","year":"2017","unstructured":"Raveendra L, Hemavathi RN, Rajgopal S (2017) A study of Vitiligo in type 2 Diabetic patients. Indian J Dermatol 62:168. https:\/\/doi.org\/10.4103\/IJD.IJD_360_16","journal-title":"Indian J Dermatol"},{"key":"3117_CR6","doi-asserted-by":"crossref","unstructured":"Ibrahim S, El-Tahlawi S, Mogawer RM, El Ansary M, Esmat S, El-Hawary M (2022) Different vitiligo characteristics as predictors of increased risk of metabolic syndrome and insulin resistance: a case\u2013control study. J Cosmet Dermatol ;21","DOI":"10.1111\/jocd.15446"},{"key":"3117_CR7","doi-asserted-by":"crossref","unstructured":"Chuang KW, Chang HC (2022) Association between Vitiligo and metabolic syndrome: a systematic review and meta-analysis. JDDG - J German Soc Dermatology ;20","DOI":"10.1111\/ddg.14652"},{"key":"3117_CR8","unstructured":"Third Report of the National Cholesterol Education Program (2001) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on. 01-3670"},{"key":"3117_CR9","doi-asserted-by":"crossref","unstructured":"Alberti KGMM, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S"},{"key":"3117_CR10","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373\u2013383","journal-title":"J Chronic Dis"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-024-03117-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-024-03117-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T16:35:01Z","timestamp":1725899701000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-024-03117-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,15]]},"references-count":10,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,9]]}},"alternative-id":["3117"],"URL":"https:\/\/doi.org\/10.1007\/s00403-024-03117-7","relation":{},"ISSN":["1432-069X"],"issn-type":[{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,15]]},"assertion":[{"value":"24 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"ADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors have any conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"408"}}